Vital Chemtech Reports Financial Results for Q4 FY26 and FY26
Vital Chemtech Limited announced its financial results for the quarter and year ended March 31, 2026. The company's performance highlights included a significant year-on-year improvement in EBITDA for Q4 FY26, while attributing declines in Profit After Tax (PAT) both quarterly and annually to investments in its two subsidiaries.The financial results reveal the following key figures for the periods ending March 31, 2026:
| Financial Metric (₹ crores) | Q4 FY26 | Q4 FY25 | YoY change (%) | FY26 | FY25 | YoY change (%) |
|---|---|---|---|---|---|---|
| Revenue from operations | 35.1 | 35.1 | 0.2% | 126.4 | 133.9 | -5.6% |
| EBITDA | 4.0 | 2.8 | 39.7% | 10.0 | 10.6 | -5.6% |
| EBITDA Margin | 11.3% | 8.1% | 320 bps | 7.9% | 7.9% | 0 bps |
| Profit after tax | 0.8 | 1.2 | -28.2% | 1.0 | 4.0 | -74.1% |
| PAT Margin | 2.4% | 3.3% | -95 bps | 0.8% | 3.0% | -215 bps |
| EPS (₹) | 0.4 | 0.5 | -26.5% | 0.4 | 1.7 | -74.1% |
Performance Highlights
Q4 FY26 PerformanceRevenue from operations for Q4 FY26 was reported at ₹35.1 crore, showing stability year-on-year, reflecting the company's resilient business performance amidst global disruptions. EBITDA for the quarter stood at ₹4.0 crore, marking a 39.7% year-on-year growth compared to Q4 FY25. Operational efficiencies led to an improvement in EBITDA margins by 320 basis points, reaching 11.3%. Profit After Tax (PAT) for Q4 FY26 was ₹0.8 crore, a decline of 28.2% year-on-year. This contraction in PAT margins to 2.4% was primarily attributed to investments made in the two subsidiaries, Vital Synthesis and Vital Alkoxides.
FY26 Results
For the full fiscal year, revenue from operations for FY26 was ₹126.4 crore, registering a 5.6% decline year-on-year compared to FY25. The company's EBITDA for FY26 was approximately ₹10.0 crore, declining by 5.6% year-on-year. Despite the moderate earnings dip, the EBITDA margin remained stable at 7.9%, aligning with FY25. PAT for FY26 stood at ₹1.0 crore, resulting in a PAT margin of 0.8%, significantly lower than the 3.0% recorded in FY25, also due to investments in the subsidiaries.
Operational Growth and Outlook
The company emphasized the strengthening of its long-term growth platform through its subsidiaries. During FY26, Vital Synthesis Limited commenced commercial operations in Q3 FY26 and received encouraging customer response, with expectations of gradual scale-up. Vital Alkoxides Private Limited also demonstrated strong business momentum during the year, achieving approximately 63% year-on-year revenue growth.Mr. Vipul Bhatt, Chairman and MD, commented that in FY26, Vital Chemtech focused on bolstering its business foundation through strategic investments and operational improvements across specialty chemical segments. He noted that while these investments impacted short-term profitability, they are expected to reinforce the group's growth platform and diversification strategy.
The company remains focused on improving capacity utilization and optimizing the product mix. Vital Chemtech Limited, which is headquartered in Ahmedabad, specializes in producing key phosphorus derivative products and various specialty chemicals for high-growth industries. The group also benefits from its integrated manufacturing facility located at Dahej, Gujarat.
VITAL Stock Price Movement
Vital Chemtech Limited shares today slipped by 4.99% to settle at ₹51.97. The stock recorded a drop of ₹2.73 on a volume of 16,762 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: